167 related articles for article (PubMed ID: 30858692)
1. Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives.
Bimonte S; Albino V; Piccirillo M; Nasto A; Molino C; Palaia R; Cascella M
Drug Des Devel Ther; 2019; 13():611-621. PubMed ID: 30858692
[TBL] [Abstract][Full Text] [Related]
2. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
Yang H; Wang M; Sun H; Zhu S; Jin J
Pharmacology; 2019; 104(5-6):267-275. PubMed ID: 31434088
[TBL] [Abstract][Full Text] [Related]
3. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
[TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.
Kaufmann R; Henklein P; Henklein P; Settmacher U
Oncol Rep; 2009 May; 21(5):1261-7. PubMed ID: 19360302
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.
Tang Y; Cao J; Cai Z; An H; Li Y; Peng Y; Chen N; Luo A; Tao H; Li K
Mol Med Rep; 2020 Nov; 22(5):3873-3885. PubMed ID: 33000276
[TBL] [Abstract][Full Text] [Related]
7. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Sojoodi M; Wei L; Erstad DJ; Yamada S; Fujii T; Hirschfield H; Kim RS; Lauwers GY; Lanuti M; Hoshida Y; Tanabe KK; Fuchs BC
Cancer Prev Res (Phila); 2020 Jun; 13(6):497-508. PubMed ID: 32253266
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
[TBL] [Abstract][Full Text] [Related]
10. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells.
Nishida H; Omori M; Fukutomi Y; Ninomiya M; Nishiwaki S; Suganuma M; Moriwaki H; Muto Y
Jpn J Cancer Res; 1994 Mar; 85(3):221-5. PubMed ID: 7514585
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
Shen X; Zhang Y; Feng Y; Zhang L; Li J; Xie YA; Luo X
Int J Oncol; 2014 Mar; 44(3):791-6. PubMed ID: 24402647
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.
Li S; Wu L; Feng J; Li J; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Kong R; Chen K; Wang F; Xia Y; Lu J; Zhou Y; Dai W; Guo C
Sci Rep; 2016 Jun; 6():28479. PubMed ID: 27349173
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
15. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer.
Bimonte S; Cascella M; Leongito M; Palaia R; Caliendo D; Izzo F; Cuomo A
Recenti Prog Med; 2017 Jun; 108(6):282-287. PubMed ID: 28631776
[TBL] [Abstract][Full Text] [Related]
16. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.
Wen Y; Zhao RQ; Zhang YK; Gupta P; Fu LX; Tang AZ; Liu BM; Chen ZS; Yang DH; Liang G
Oncotarget; 2017 May; 8(18):29760-29770. PubMed ID: 28423656
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
[TBL] [Abstract][Full Text] [Related]
18. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
19. [MDR-reversing effect of two components of catechin on human hepatocellular carcinoma BEL-7404/Adr in vitro].
Liang G; Zhang S; Huang ZM; Tang AZ
Ai Zheng; 2004 Apr; 23(4):401-5. PubMed ID: 15087027
[TBL] [Abstract][Full Text] [Related]
20. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
